Loading clinical trials...
Loading clinical trials...
Cholangitis is the most common postoperative complication of biliary atresia, with a reported incidence of 40-90%, which seriously affects the surgical effect, survival rate and the quality of life an...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nanjing Children's Hospital
NCT07304843 · Primary Biliary Cholangitis (PBC)
NCT07640243 · Fragility, Biliary Obstruction, and more
NCT05848310 · Biliary Atresia, Prognosis
NCT06519162 · Autoimmune Hepatitis, Primary Sclerosing Cholangitis, and more
NCT07229911 · Healthy Volunteers, Primary Sclerosing Cholangitis
NJMU
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions